Long pages

Jump to navigation Jump to search

Showing below up to 50 results in range #1,101 to #1,150.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. (hist) ‎Thayer SP, et al. Nature (2003) cited as Ref 598 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  2. (hist) ‎Yuan Z, et al. Oncogene (2007) cited as Ref 597 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  3. (hist) ‎Mukherjee S, et al. Cancer Biol. Ther. (2006) cited as Ref 596 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  4. (hist) ‎Smith DC, et al. Clin. Cancer Res. (2014) cited as Ref 595 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  5. (hist) ‎Yang J, et al. J. Cell. Mol. Med. (2019) cited as Ref 594 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  6. (hist) ‎Papayannidis C, et al. Blood Cancer J. (2015) cited as Ref 593 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  7. (hist) ‎Messersmith WA, et al. Clin. Cancer Res. (2015) cited as Ref 592 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  8. (hist) ‎Kummar S, et al. J. Clin. Oncol. (2017) cited as Ref 591 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  9. (hist) ‎LoConte NK, et al. Invest. N. Drugs (2015) cited as Ref 590 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  10. (hist) ‎Sahebjam S, et al. Br. J. Cancer (2013) cited as Ref 589 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  11. (hist) ‎Richter S, et al. Invest N. Drugs (2014) cited as Ref 588 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  12. (hist) ‎Diaz-Padilla I, et al. Gynecol. Oncol. (2015) cited as Ref 587 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  13. (hist) ‎De Jesus-Acosta A, et al. Invest. N. Drugs (2014) cited as Ref 586 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  14. (hist) ‎Strosberg JR, et al. Eur. J. Cancer (2012) cited as Ref 585 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  15. (hist) ‎Tolcher AW, et al. J. Clin. Oncol. (2012) cited as Ref 584 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  16. (hist) ‎Luistro L, et al. Cancer Res. (2009) cited as Ref 583 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  17. (hist) ‎Zhang S, et al. Cancer Biol. Ther. (2014) cited as Ref 582 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  18. (hist) ‎Brana I, et al. Br. J. Cancer (2014) cited as Ref 581 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  19. (hist) ‎Cook N, et al. Br. J. Cancer (2018) cited as Ref 580 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  20. (hist) ‎Schott AF, et al. Clin. Cancer Res. (2013) cited as Ref 579 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  21. (hist) ‎Chen X, et al. Gynecol. Oncol. (2016) cited as Ref 578 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  22. (hist) ‎Hoffman LM, et al. Childs Nerv. Syst. (2015) cited as Ref 577 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  23. (hist) ‎Krop I, et al. J. Clin. Oncol. (2012) cited as Ref 576 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  24. (hist) ‎Fouladi M, et al. J. Clin. Oncol. (2011) cited as Ref 575 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  25. (hist) ‎Hayakawa Y, et al. Gastroenterology (2019) cited as Ref 574 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  26. (hist) ‎Mamidi A, et al. Nature (2018) cited as Ref 573 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  27. (hist) ‎Dai W, et al. Nat. Commun. (2017) cited as Ref 572 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  28. (hist) ‎Gazdar AF, et al. Nat. Rev. Cancer (2017) cited as Ref 571 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  29. (hist) ‎Zanotti S, et al. Endocr. Rev. (2016) cited as Ref 570 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  30. (hist) ‎Van Groningen T, et al. Nat. Commun. (2019) cited as Ref 569 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  31. (hist) ‎Rajakulendran N, et al. Genes Dev. (2019) cited as Ref 568 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  32. (hist) ‎Nowell CS, et al. Nat. Rev. Cancer (2017) cited as Ref 567 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  33. (hist) ‎Meurette O, et al. Cancer Cell (2018) cited as Ref 566 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  34. (hist) ‎Quail DF, et al. Curr. Stem Cell Res Ther. (2012) cited as Ref 565 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  35. (hist) ‎Schmidt M, et al. Ann. Oncol. (2010) cited as Ref 564 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  36. (hist) ‎Niedzwiecki D, et al. J. Clin. Oncol. (2011) cited as Ref 563 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  37. (hist) ‎Jaeger M, et al. J. Clin. Oncol. (2004) cited as Ref 562 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  38. (hist) ‎Sebastian M, et al. Cancer Immunol. Immunother. (2007) cited as Ref 561 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  39. (hist) ‎Oberneder R, et al. Eur. J. Cancer (2006) cited as Ref 560 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  40. (hist) ‎Osta WA, et al. Cancer Res. (2004) cited as Ref 559 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  41. (hist) ‎Pemmaraju N, et al. Blood (2016) cited as Ref 558 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  42. (hist) ‎Frankel AE, et al. Blood (2014) cited as Ref 557 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  43. (hist) ‎He SZ, et al. Leuk. Lymphoma (2015) cited as Ref 556 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  44. (hist) ‎Riechelmann H, et al. Oral. Oncol. (2008) cited as Ref 555 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  45. (hist) ‎Colnot DR, et al. Cancer Immunol. Immunother. (2003) cited as Ref 554 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  46. (hist) ‎Postema EJ, et al. J. Nucl. Med. (2003) cited as Ref 553 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  47. (hist) ‎Borjesson PK, et al. Clin. Cancer Res. (2003) cited as Ref 552 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  48. (hist) ‎Nabhan C, et al. Leuk. Lymphoma (2004) cited as Ref 551 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  49. (hist) ‎Turner JH, et al. Cancer Biother. Radiopharm. (2003) cited as Ref 550 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  50. (hist) ‎Ghielmini M, et al. Ann. Oncol. (2000) cited as Ref 549 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)